Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The closing price of Achieve Life Sciences Inc (NASDAQ: ACHV) was $2.66 for the day, up 4.31% from the previous closing price of $2.55. In other words, the price has increased by $4.31 from its previous closing price. On the day, 0.52 million shares were traded. ACHV stock price reached its highest trading level at $2.74 during the session, while it also had its lowest trading level at $2.545.
Ratios:
Our analysis of ACHV’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.64 and its Current Ratio is at 6.64. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.21.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on November 14, 2024, initiated with a Buy rating and assigned the stock a target price of $12.
On September 27, 2024, Raymond James started tracking the stock assigning a Strong Buy rating and target price of $20.
Maxim Group reiterated its Buy rating for the stock on May 10, 2023, while the target price for the stock was revised from $8 to $20.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 17 ’25 when Oki Mark K bought 10,000 shares for $2.89 per share. The transaction valued at 28,887 led to the insider holds 10,000 shares of the business.
Stewart Richard Alistair bought 10,000 shares of ACHV for $28,598 on Mar 17 ’25. The Chieve Executive Officer now owns 60,876 shares after completing the transaction at $2.86 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACHV now has a Market Capitalization of 135939312 and an Enterprise Value of 90502216.
Stock Price History:
The Beta on a monthly basis for ACHV is 1.53, which has changed by -0.39682537 over the last 52 weeks, in comparison to a change of 0.15222645 over the same period for the S&P500. Over the past 52 weeks, ACHV has reached a high of $5.31, while it has fallen to a 52-week low of $1.84. The 50-Day Moving Average of the stock is -4.74%, while the 200-Day Moving Average is calculated to be -16.88%.
Shares Statistics:
ACHV traded an average of 949.61K shares per day over the past three months and 660300 shares per day over the past ten days. A total of 49.69M shares are outstanding, with a floating share count of 43.28M. Insiders hold about 15.32% of the company’s shares, while institutions hold 53.95% stake in the company. Shares short for ACHV as of 1753920000 were 2790559 with a Short Ratio of 2.94, compared to 1751241600 on 2180807. Therefore, it implies a Short% of Shares Outstanding of 2790559 and a Short% of Float of 6.64.
Earnings Estimates
As of right now, 4.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.27, with high estimates of -$0.23 and low estimates of -$0.34.
Analysts are recommending an EPS of between -$1.19 and -$1.43 for the fiscal current year, implying an average EPS of -$1.29. EPS for the following year is -$0.63, with 6.0 analysts recommending between $1.31 and -$1.38.
